paquinimod
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2009 (NCT00997100)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Protein S100-A8INHIBITOR
inhibitor - S100A8
Chemistry & pharmacology
Loading structure…
SMILES
CCc1cccc2c1c(O)c(C(=O)N(CC)c1ccccc1)c(=O)n2C- Mol. weight
- 350.42 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL67776 ↗
Also known as
- abr-215757
- paquinimod
- paquinimod
- paquinimod
- paquinimod
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01487551 | Phase 2 | Dec 1, 2011 | Active Biotech AB, Lund University |
| NCT00997100 | Phase 2 | Aug 1, 2009 | Active Biotech AB |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Active Biotech AB | For profit | 2 | 2 | 1 | 2009 |
| Lund University | Academic/Hospital | 1 | 0 | 1 | 2011 |
2 organizations
Page 1 / 1